iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
66 hedge funds and large institutions have $46.4M invested in iShares Genomics Immunology and Healthcare ETF in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 14 closing their positions.
Holders
66
Holders Change
-6
Holders Change %
-8.33%
% of All Funds
1.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
15
Reduced
16
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EIP
76
Ellis Investment Partners
Berwyn,
Pennsylvania
| – | – | -131 | Closed |
|
77
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | – | -56 | Closed |
|
78
Fidelity Investments
Boston,
Massachusetts
| – | – | -8 | Closed |
|
|
CFGS
79
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
AF
80
Advisornet Financial
Minnetonka,
Minnesota
| $0 | 12 | – | – |
|
|
FHA
81
First Horizon Advisors
Memphis,
Tennessee
| $0 | 10 | – | – |
|